American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3
Ted R. Mikuls(Nebraska Medical Center), Kenneth G. Saag(University of Alabama at Birmingham), Sindhu R. Johnson(Toronto Western Hospital), Bonnie L. Bermas(The University of Texas Southwestern Medical Center), Michael E. Weinblatt(Brigham and Women's Hospital), Reuben J. Arasaratnam(VA North Texas Health Care System), Stanley Cohen(Metroplex Clinical Research Center), André C. Kalil(Nebraska Medical Center), Amy S. Mudano(University of Alabama at Birmingham), Amy S. Turner(American College of Rheumatology), Karen H. Costenbader(Brigham and Women's Hospital), Liana Fraenkel(Berkshire Medical Center), Lindsey R. Baden(Brigham and Women's Hospital), Kevin Winthrop(Oregon Health & Science University), Winn Chatham(University of Alabama at Birmingham), Ellen M. Gravallese(Brigham and Women's Hospital)
Cited by 242
Related Papers
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
|Annals of the Rheumatic Diseases|2019|1.5k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k